NBDC Research ID: hum0176.v1

 

SUMMARY

Aims: Comprehensive sequencing analyses of uterine and ovarian carcinosarcoma

Methods: Exome / target caputer analysis by using Illumina Hiseq 2000

Participants/Materials: 109 primary tumor and mached normal (non-tumor) tissues from uterin or ovarian carcinosarcoma patients

 

Dataset IDType of DataCriteriaRelease Date
JGAS000172 NGS (Exome, Target Capture) Controlled-access (Type I) 2019/10/02

*Release Note

* Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

Exome

Participants/Materials

Uterine carcinosarcoma (ICD10: C549): 1 case (2 samples)

Ovarian carcinosarcoma (ICD10: C56): 3 case (6 samples)

Targets Exome
Target Loci for Capture Methods -
Platform Illumina [HiSeq 2000]
Library Source DNAs extracted from tumor and paired non-tumor tissues
Cell Lines -
Library Construction (kit name) SureSelect Human All Exon V4 or V5
Fragmentation Methods Ultrasonic fragmentation (Covaris)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 101 bp
Japanese Genotype-phenotype Archive Dataset ID JGAD000250
Total Data Volume 646 GB (fastq)
Comments (Policies) NBDC policy

 

Target Capture

Participants/Materials

Uterine carcinosarcoma (ICD10: C549): 91 case (182 samples)

Ovarian carcinosarcoma (ICD10: C56): 14 case (28 samples)

Targets Target Capture (CS-A, CS-B)
Target Loci for Capture Methods

CS-A: 491 genes, 2.605 Mbps

CS-B: 114 genes, 422.9 kbps

Platform Illumina [HiSeq 2000]
Library Source DNAs extracted from tumor and paired non-tumor tissues
Cell Lines -
Library Construction (kit name) SureSelect XT Custom
Fragmentation Methods Ultrasonic fragmentation (Covaris)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 101 bp
Japanese Genotype-phenotype Archive Dataset ID JGAD000250
Total Data Volume 646 GB (fastq)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Seiichi Mori

Affiliation: Cancer Precison Medicine Center

Project / Group Name: -

Funds / Grants (Research Project Number):

NameTitleProject Number
The Vehicle Racing Commemorative Foundation Exploration of relevant mutations associated with relapsing or refractory ovarian cancer. 5144, 5274, and 5393
KAKENHI Grant-in-Aid for Scientific Research (C) Genome-wide analyses of endometrial endometrioid carcinoma for early detection and personalized medicine. 26462543
KAKENHI Grant-in-Aid for Scientific Research (C) Molecular analysis of malignant ascites formation by single-cell RNA-sequencing. 15K06861
KAKENHI Grant-in-Aid for Scientific Research (C) Identification of the progestin therapy resistance genes in time-course endometrial cancer samples. 17K11308
KAKENHI Grant-in-Aid for Young Scientists (B) Whole genome sequencing analyses of uterine and ovarian carcinosarcoma. 17K18337
KAKENHI Grant-in-Aid for Scientific Research (C) Immune microenvironment analyses of uterine and ovarian carcinosarcoma. 18K07338

 

PUBLICATIONS

TitleDOIDataset ID
1
2

 

USRES (Controlled-access Data)

Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use
Masaki Mandai Kyoto University Faculty of Medicene, department of Gynecology and Obstetrics Elucidation of immune-system networks between host and tumor based on genomic analysis JGAD000250 2020/03/13-2025/03/31
Kouya Shiraishi Division of Genome Biology, National Cancer Research Institute Elucidation of immune-system networks between host and tumor based on genomic analysis JGAD000250 2020/09/18-2023/03/31
Noriomi Matsumura Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University Japan Integrated multi-omics analysis for ovarian clear cell adenocarcinoma: JGOG3017-TR1 JGAD000250 2024/10/15-2027/12/31
Ken Yamaguchi Gynecology and Obstetrics, Graduate School of Medicine and Faculty of Medicine, Kyoto University Japan Integrated multi-omics analysis for ovarian clear cell adenocarcinoma: JGOG3017-TR1 JGAD000250 2024/10/22-2027/12/31